• Home
• t rest
• Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

5 (698) · $ 12.50 · In stock

Comprehensive analysis of the transcription factor REST regulatory networks in IDH-mutant and IDH-wild type glioma cells and gliomas

REST Polyclonal Antibody (22242-1-AP)

Elledge Lab

REST in the Road Map of Brain Development

REST Polyclonal Antibody (22242-1-AP)

The overexpression and clinical significance of TBX15 in human

Serum sCTLA-4 levels in patients with glioma and in controls

Knockdown of VIM-AS1 increased glioma the cell apoptosis. A-B

IJMS, Free Full-Text